Hasselbalch HC - Search Results

1

[Status and perspectives on chronic myeloproliferative neoplasm treatment].

Ocias LF, Holmström MO, Riley CH, Andersen CL, Rønnov-Jessen D, Starklint J, Frederiksen M, Steffensen MS, Bjerrum OW, Farmer S, Mourits-Andersen T, Hasselbalch HC, Larsen TS. Ocias LF, et al. Among authors: hasselbalch hc. Ugeskr Laeger. 2015 May 4;177(19):V12140652. Ugeskr Laeger. 2015. PMID: 25967090 Free article. Review. Danish.

2

[Clinical use of recombinant human thrombopoietin. Status and perspectives].

Hansen PB, Hasselbalch HC. Hansen PB, et al. Among authors: hasselbalch hc. Ugeskr Laeger. 2001 May 7;163(19):2659-62. Ugeskr Laeger. 2001. PMID: 11360368 Review. Danish.

3

[The chronic Philadelphia chromosome-negative myeloproliferative syndrome I. Pathogenesis and pathophysiology].

Hasselbalch HC, Mourits-Andersen HT, Jensen BA, Jensen MK, Nielsen OJ. Hasselbalch HC, et al. Ugeskr Laeger. 2001 Apr 30;163(18):2471-3. Ugeskr Laeger. 2001. PMID: 11379259 Review. Danish.

4

[The chronic Philadelphia chromosome-negative myeloproliferative syndrome II. Clinical findings, diagnostics and treatment].

Hasselbalch HC, Mourits-Andersen HT, Jensen BA, Jensen MK, Nielsen OJ. Hasselbalch HC, et al. Ugeskr Laeger. 2001 Apr 30;163(18):2474-7. Ugeskr Laeger. 2001. PMID: 11379260 Review. Danish.

5

[Acute thrombotic complication at the debute of the Philadelphia chromosome-negative myeloproliferative syndrome].

Hasselbalch HC, Mourits-Andersen HT, Jensen BA, Jensen MK, Nielsen OJ. Hasselbalch HC, et al. Ugeskr Laeger. 2001 Apr 30;163(18):2478-81. Ugeskr Laeger. 2001. PMID: 11379261 Danish.

6

[STI571 (Glivec)--a new drug for the treatment of chronic myeloid leukemia].

Hasselbalch HC. Hasselbalch HC. Ugeskr Laeger. 2002 May 27;164(22):2914-7. Ugeskr Laeger. 2002. PMID: 12082821 Review. Danish.

7

[Immunosuppressive treatment of the myelodysplastic syndrome].

Larsen MS, Hasselbalch HC. Larsen MS, et al. Among authors: hasselbalch hc. Ugeskr Laeger. 2003 Jun 23;165(26):2654-7. Ugeskr Laeger. 2003. PMID: 12886548 Danish.

8

Collagen metabolism and enzymes of the urokinase plasminogen activator system in chronic myeloproliferative disorders: correlation between plasma-soluble urokinase plasminogen activator receptor and serum markers for collagen metabolism.

Jensen MK, Riisbro R, Holten-Andersen MN, Brown Pde N, Junker P, Brünner N, Hasselbalch HC. Jensen MK, et al. Among authors: hasselbalch hc. Eur J Haematol. 2003 Oct;71(4):276-82. doi: 10.1034/j.1600-0609.2003.00134.x. Eur J Haematol. 2003. PMID: 12950237

9

Anagrelide treatment in 52 patients with chronic myeloproliferative diseases.

Penninga E, Jensen BA, Hansen PB, Clausen NT, Mourits-Andersen T, Nielsen OJ, Hasselbalch HC. Penninga E, et al. Among authors: hasselbalch hc. Clin Lab Haematol. 2004 Oct;26(5):335-40. doi: 10.1111/j.1365-2257.2004.00637.x. Clin Lab Haematol. 2004. PMID: 15485463 Clinical Trial.

10

Rituximab chimeric anti-CD20 monoclonal antibody treatment for adult refractory idiopathic thrombocytopenic purpura.

Braendstrup P, Bjerrum OW, Nielsen OJ, Jensen BA, Clausen NT, Hansen PB, Andersen I, Schmidt K, Andersen TM, Peterslund NA, Birgens HS, Plesner T, Pedersen BB, Hasselbalch HC. Braendstrup P, et al. Among authors: hasselbalch hc. Am J Hematol. 2005 Apr;78(4):275-80. doi: 10.1002/ajh.20276. Am J Hematol. 2005. PMID: 15795920 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

299 results

Search Page